FDA.reportPublic FDA data

Bepreve 1.5 % Ophthalmic Solution

RxCUI
863042
RxNorm name
Bepreve 1.5 % Ophthalmic Solution
Display name
Bepreve 1.5 % Ophthalmic Solution
Full name
Bepreve 1.5 % Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BepreveBEPOTASTINE BESILATEBausch & Lomb Incorporated68bbf6a0-c4b5-47c1-8a1c-08220fbdbce62022-08-31Warnings, Adverse reactionsExact identifier
rxcui: 863042

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6Bepreve 1.5 % Ophthalmic SolutionSY14These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 200920220831
68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6Bepreve 15 MG/ML Ophthalmic SolutionSY14These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 200920220831
68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve]SBD14These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 200920220831
68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6BEPREVE 1.5 % Ophthalmic SolutionPSN14These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 200920220831
7c77517f-24c7-4778-94a7-873d11c3c657bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve]SBD1These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 200920090801
7c77517f-24c7-4778-94a7-873d11c3c657Bepreve 1.5 % Ophthalmic SolutionSY1These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 200920090801
7c77517f-24c7-4778-94a7-873d11c3c657BEPREVE 1.5 % Ophthalmic SolutionPSN1These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 200920090801
7c77517f-24c7-4778-94a7-873d11c3c657Bepreve 15 MG/ML Ophthalmic SolutionSY1These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 200920090801